未知股票 RPHM 深 沪
已收盘 10-04 16:00:00 美东时间
1.82
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 1.82
- 总市值 6151.75万
- 52周最高 --
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 总股本 3380.08万
- 历史最高 --
- 量 比 0
- 振 幅 0.00%
- 历史最低 --
- 每 手 1
- 风险率 20.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Recently Listed Cancer Firm OnKure's Innovative Approach to Breast Cancer Treatment Sparks Analyst Enthusiasm
OnKure Therapeutics has garnered attention following its merger with Reneo Pharmaceuticals and a $65 million private placement. Oppenheimer initiated coverage with an Outperform rating, highlighting the potential of OKI-219 in targeting breast cancer mutations.
2024-10-11 02:43
Reneo Pharmaceuticals: Navigating Financial Challenges and Corporate Changes
The latest announcement is out from Reneo Pharmaceuticals ( ($RPHM) ). OnKure, ...
2024-10-09 05:48
快讯 | Reneo制药公司：计划在2024年第四季度公布首个项目的早期临床数据
Reneo Pharmaceuticals Inc: On Track to Announce Early Clinical Data for Lead Pr...
2024-10-05 05:09
快讯 | Reneo制药公司：预计资金支持到2026年第四季度
Reneo Pharmaceuticals Inc: Expected Funding Runway Into Q4-2026
2024-10-05 05:08
快讯 | Onkure宣布与Reneo Pharmaceuticals完成合并，并同时进行6500万美元的定向增发
Onkure Announces Closing of Merger With Reneo Pharmaceuticals and Concurrent Pr...
2024-10-05 04:57
Reneo stockholders approve merger with OnKure
Reneo Pharmaceuticals (NASDAQ:RPHM) stockholders voted in favor of all proposals, including the proposals required to complete the proposed merger of Reneo and OnKure. OnKure is a clinical-stage bioph...
2024-10-03 18:05
Exicure Stock Is Soaring After The Bell: What's Driving The Action?
Shares of low-float micro-cap stock Exicure are rocketing higher in Wednesday's after-hours session after the company announced that it received an extension from the Nasdaq Hearings Panel.
2024-09-19 04:51
Reneo Pharmaceuticals Announces Merger and Executive Departure
Reneo Pharmaceuticals ( ($RPHM) ) has issued an announcement. Reneo Pharmaceuti...
2024-09-14 04:50
快讯 | Reneo制药报告2024年第二季度财务数据
Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results
2024-08-13 19:35
